Abstract
We report here on a novel metallothionein-I (MT)/ret transgenic mouse line in which skin melanosis, benign melanocytic tumor and malignant melanoma metastasizing to distant organs develop stepwise. The process of tumor development and its malignant transformation in this line may resemble that of the human giant congenital melanocytic nevus that is present at birth and that frequently gives rise to malignant melanoma during aging. We observed an increase in the expression level and activity of the ret transgene during the disease progression. That increase in transgene expression accompanied an activation of mitogen-activated protein kinases (MAPKs) and c-Jun as well as matrix metalloproteinases. These results suggest that progressive dysregulation of the expression level of the ret transgene might play a crucial role in the malignant transformation of melanocytic tumors developed in the MT/ret transgenic mouse line.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kato, M., Takahashi, M., Akhand, A. et al. Transgenic mouse model for skin malignant melanoma. Oncogene 17, 1885–1888 (1998). https://doi.org/10.1038/sj.onc.1202077
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202077
Keywords
This article is cited by
-
Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling
Cancer Cell International (2023)
-
ComplexEye: a multi-lens array microscope for high-throughput embedded immune cell migration analysis
Nature Communications (2023)
-
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Journal of Translational Medicine (2022)
-
Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases
Scientific Reports (2021)
-
IER2-induced senescence drives melanoma invasion through osteopontin
Oncogene (2021)